Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Transocean Ltd (RIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Transocean Ltd — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B), while Transocean Ltd trades at $5.57 (market cap $6.19B). The key difference: Transocean Ltd is far larger — about 3.6× Nuvation Bio Inc. Class A Common Stock's market cap, and Transocean Ltd is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Transocean Ltd for 18 Days on average.
| NUVB | RIG | |
|---|---|---|
Market Cap | $1.74B | $6.19B |
Volume | 9,289,619 | 30,564,415 |
Sector | Health | Energy |
52-Week High | $9.54 | $7.58 |
52-Week Low | $3.41 | $3.08 |
Typical Hold Time | 0 Days | 18 Days |
Enterprise Value | $1.33B | $10.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Transocean (RIG) trades at $5.39, down slightly by 0.19%, with a bearish technical signal from moving averages. The company reported a net loss of $2.92 billion in 2025, though revenue remains stable near $4 billion. Recent news highlights the $5.8 billion Valaris acquisition, approved by the DOJ, and new contracts like the $80 million deal for the Deepwater Conqueror, providing operational momentum amid a challenging profitability landscape.
The outlook is speculative, hinging on successful deleveraging and integration of the Valaris deal to improve cash flow. Key risks include high debt levels, execution challenges, and persistent negative margins. Analyst sentiment is mixed, with a 39% buy rating, reflecting cautious optimism tied to offshore cycle strength and debt reduction progress.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Transocean Ltd
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →
